Search clinical trials for: oxaliplatin (SR96669)
Total 1785 results
-
SanofiCompletedGastrointestinal CancerUnited States
-
SanofiCompletedColonic NeoplasmsFrance, Poland, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Singapore, Belgium, Denmark, Hungary, Israel, Norway, United Kingdom, Australia, Austria, Greece
-
SanofiWithdrawn
-
SanofiRegeneron PharmaceuticalsWithdrawn
-
Hallym University Medical CenterSanofiCompletedColorectal NeoplasmKorea, Republic of
-
Asan Medical CenterSeoul National University Bundang Hospital; Severance Hospital; Hallym University... and other collaboratorsRecruitingGastric Cancer, Adjuvant Chemotherapy, XOKorea, Republic of
-
Fudan UniversityCompleted
-
Qun ZhaoJiangsu HengRui Medicine Co., Ltd.Completed
-
The Lymphoma Academic Research OrganisationInnate PharmaRecruitingPeripheral T Cell Lymphoma | Relapse/RecurrenceFrance, Spain, Belgium, Germany
-
SanofiRegeneron PharmaceuticalsTerminated
-
Fundación para el Progreso de la Oncología en CantabriaCompletedStage IV Gastric Cancer With MetastasisSpain
-
Xijing HospitalUnknownGastrointestinal CancerChina
-
SanofiCompletedGastric CancerKorea, Republic of
-
Lin ChenUnknownGastric AdenocarcinomaChina
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Chonnam National University... and other collaboratorsCompletedColorectal CancerKorea, Republic of
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical CancerUnited States, Canada
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceSuspended
-
University of ChicagoNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States
-
European Organisation for Research and Treatment...TerminatedBreast CancerFrance, Belgium, Slovenia, Israel, United Kingdom, Germany, Austria
-
Jenny DrottCompletedColorectal NeoplasmsSweden
-
SanofiCompleted
-
University of California, DavisNational Cancer Institute (NCI)Completed
-
Samsung Medical CenterUnknownColon CancerKorea, Republic of
-
Sixth Affiliated Hospital, Sun Yat-sen UniversitySun Yat-sen UniversityRecruitingChemotherapy Effect | Locally Advanced Gastroesophageal Junction AdenocarcinomaChina
-
Hasselt UniversityZiekenhuis Oost-LimburgUnknownColorectal Peritoneal CarcinomatosisBelgium
-
Samsung Medical CenterUnknownCuratively-resected, Node-positive Esophageal Squamous Cell CarcinomaKorea, Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)Completed
-
Hospital Alemão Oswaldo CruzRecruitingRectal Cancer | ConsolidationBrazil, Argentina, Uruguay
-
National Cancer Center, KoreaUnknownStomach NeoplasmsKorea, Republic of
-
AIPING ZHOURecruiting
-
Samsung Medical CenterCompletedColorectal NeoplasmsKorea, Republic of
-
Samsung Medical CenterUnknown
-
Edward KimNational Cancer Institute (NCI)CompletedColon AdenocarcinomaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedColorectal Cancer | Primary Peritoneal Cavity Cancer | Carcinoma of the AppendixUnited States
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityUnknown
-
Roswell Park Cancer InstituteCompletedColorectal CancerUnited States
-
SanofiCompletedColonic NeoplasmsHong Kong, Korea, Republic of, Taiwan, Thailand, China
-
Prologue Research InternationalCompletedColorectal CancerUnited States
-
Samsung Medical CenterTerminatedPhase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/OxaliplatinKorea, Republic of
-
Chinese PLA General HospitalCure&Sure Biotech Co., LTDUnknownGastric CarcinomaChina
-
Sichuan UniversityNot yet recruiting
-
Yonsei UniversityTerminatedAdvanced Gastric CancerKorea, Republic of
-
Jules Bordet InstituteCompletedOvarian Carcinoma | RelapseBelgium